Insider Selling: Zepp Health (NYSE:ZEPP) Insider Sells 5,749 Shares of Company Stock

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) insider Pengtao Yu sold 5,749 shares of the stock in a transaction dated Wednesday, September 23rd. The stock was sold at an average price of $4.30, for a total transaction of $24,720.70. Following the sale, the insider owned 102,742 shares of the company’s stock, valued at $441,790.60. This trade represents a 5.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Pengtao Yu also recently made the following trade(s):

• On Thursday, September 24th, Pengtao Yu sold 4,251 shares of Zepp Health stock. The stock was sold at an average price of $4.09, for a total transaction of $17,386.59.

Zepp Health Stock Down 2.7%

Shares of NYSE ZEPP opened at $4.12 on Friday. The stock has a market capitalization of $60.55 million, a price-to-earnings ratio of -1.50 and a beta of 1.87. The company has a quick ratio of 0.70, a current ratio of 0.90 and a debt-to-equity ratio of 0.30. The firm has a 50-day moving average price of $4.88 and a 200 day moving average price of $8.51. Zepp Health Corporation Sponsored ADR has a 52 week low of $3.85 and a 52 week high of $61.85.

Wall Street Analysts Forecast Growth

ZEPP has been the topic of a number of recent research reports. Wall Street Zen lowered shares of Zepp Health from a “hold” rating to a “sell” rating in a report on Tuesday, September 8th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Zepp Health in a report on Tuesday, September 8th. Finally, Fundamental Research set a $53.01 price objective on shares of Zepp Health and gave the company a “buy” rating in a research note on Tuesday, August 11th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $53.01.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ZEPP. Engineers Gate Manager LP boosted its stake in shares of Zepp Health by 44.4% in the second quarter. Engineers Gate Manager LP now owns 20,917 shares of the company’s stock valued at $109,000 after purchasing an additional 6,433 shares during the period. AXQ Capital LP acquired a new stake in Zepp Health during the 2nd quarter valued at approximately $85,000. Monolith Management Ltd acquired a new position in shares of Zepp Health in the 4th quarter valued at approximately $3,601,000. Finally, Harvest Fund Management Co. Ltd increased its stake in shares of Zepp Health by 6.7% in the fourth quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company’s stock worth $1,207,000 after buying an additional 2,800 shares during the last quarter. Institutional investors and hedge funds own 52.61% of the company’s stock.

About Zepp Health

Zepp Health Corporation (NYSE: ZEPP) is a wearable technology company that develops smart health and fitness devices, along with digital platforms and services designed to help consumers monitor and improve their wellness. Its products collect and analyze information such as activity, sleep, heart rate and other health-related metrics.

The company’s principal consumer brand is Amazfit, which offers smartwatches, fitness trackers and related accessories. Zepp Health also operates the Zepp brand of digital health software and services and has introduced products and services focused on areas such as sleep and hearing health.